ANDREW KIRSCHNER: Open Payments
NPI 1710927306 · BALA CYNWYD, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$336 in 17 payments from 7 companies in 2025. Trend: 2023 $267 · 2024 $263 · 2025 $336
Food & beverage: $336
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 4 | $84 |
| ABBVIE INC. | 4 | $78 |
| Braeburn Inc. | 3 | $58 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $35 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $29 |
| Astellas Pharma US Inc | 1 | $26 |
| Indivior Inc. | 1 | $26 |
Products named: ZEPBOUND, VRAYLAR, BRIXADI, CAPLYTA, Kerendia, Veozah, SUBLOCADE, MOUNJARO.
Industry payments across PA — which companies pay providers there.
